Journals / Medeniyet Medical Journal / 2018 / Cilt: 33 - Sayı: 1

End-stage renal disease affect mortality of hip fractures treated with partial hip prosthesis in the elderly

Son dönem böbrek yetmezliği parsiyel kalça proteziyle tedavi edilmiş kalça kırığı olan yaşlı hastalardaki mortaliteyi etkiler

Pages
5–9
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

A statistically significant relationship wasfound between both groups with respect to total hospitalizationperiod (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Hip fractures are among important causes of mortality.
📊
Key Findings & Data:Patients were evaluated ascases with (Group 1: n=37), and without (Group 2: n=281) endstage renal disease.
💡
Conclusion & Impact:A statistically significant relationship wasfound between both groups with respect to total hospitalizationperiod (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Hip fractures are among important causes of mortality. Variouscomorbid factors contribute to this outcome. The end-stage renalfailure (ESRF) is an extremely important factor leads to seriouscomplications. When the presence of other comorbid diseasesis taken into consideration, the relationship between mortalityof hip fractures and end-stage renal disease was not well elucidated in the elderly population. The aim of this study was todetermine the association between hip fracture mortality andend-stage renal disease. An evaluation was made of the data ofpatients with diagnosis of hip fracture. Current status of survival or date of death was determined. Patients were evaluated ascases with (Group 1: n=37), and without (Group 2: n=281) endstage renal disease. Both groups were retrospectively comparedregarding the age, female/male ratio, cardiac ejection fraction,bone cement usage, total hospitalization time, time from initialtrauma to surgery for surgical preparation and mortality. Therewere additional comorbid diseases except renal disease. Besides the comorbidities were categorized as cardiac / pulmonary/ neurologic and diabetes mellitus and both study groups werecompared based on comorbid disease groups. There were no significant differences with respect to age (p=0.782), female: maleratio (p=0.659), ejection fraction (p=0.285), bone cement usage (p=0.971), duration of surgery (p=0,758), cardiac (p=0.570),pulmonary (p=0.875), and neurologic comorbidities (p=0.895)between two groups. A statistically significant relationship wasfound between both groups with respect to total hospitalizationperiod (p

Özet

Yaşlılarda kalça kırıkları, önemli mortalite nedenlerinden biridir. Çeşitli komorbid faktörler bu sonuca katkıda bulunur. Son derece önemli bir komorbid faktör olan son dönem böbrek yetmezliği (SDBY), ciddi komplikasyonlara neden olur. Bununla birlikte, diğer komorbid hastalıkların varlığı göz önünde bulundurulduğunda, SDBY’nin tek başına mortaliteye etkisi halen netlik kazanmamıştır ve bu çalışmada bu ilişkinin değerlendirilmesi amaçlanmıştır. Kalça kırığı tanısı ile kliniğimize başvurup parsiyel kalça artroplastisi ile tedavi edilmiş olan 65 yaş ve üstü hastalar retrospektif olarak değerlendirildi. Tüm hastalarla temasa geçildi. Ölüm meydana gelmiş ise tarihi kaydedildi. Hastalar kırık oluşumundan önce tanı koyulmuş SDBY’si olan (Grup 1, n=37) ve olmayan (Grup 2, n=281) olmak üzere 2 grupta değerlendirildi. Her iki gruptaki hastalar ortalama yaş, cinsiyet, kardiyak ejeksiyon fraksiyonu (EF), toplam hastanede kalış süresi, hastaneye yatıştan ameliyata kadar geçen süre, ameliyat süresi, çimento kullanımı ve mortalite parametreleri açısından karşılaştırıldı. Ayrıca komorbid hastalıklar kategorize edilerek kardiyak, pulmoner, nörolojik komorbid hastalıklar ve diabetes mellitus (DM) gruplarına ayrıldı. Her iki grup ek hastalık kategorileri açısından karşılaştırıldı. Yaş ortalaması (p=0,782), cinsiyet (p=0,659), EF (p=0,285), çimento kullanımı (p=0,971) ve ameliyat süresi (p=0,758) açısından gruplar arasından anlamlı fark yoktu. Gruplar arasında toplam hastaneye yatış süresi (p

🔖

Cite This Article

BULUT, T., ZENGİN, E. C., ÖZCAN, C., TAHTA, M., ŞENER, M., ÖZTÜRK, T. (2022). End-stage renal disease affect mortality of hip fractures treated with partial hip prosthesis in the elderly. Medeniyet Medical Journal, Cilt: 33 - Sayı: 1, 5–9. https://ajindex.com/articles/579294

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Osnes EK, Lofthus CM, Meyer HE, Falch JA et al. Consequences of hip fracture on activities of daily life and residential needs. Osteoporos Int. 2004;15:567-74. https://doi.org/10.1007/s00198-003-1583-0
  2. Sener M, Onar V, Kazimoğlu C, Yağdi S. Mortality and morbidity in elderly patients who underwent partial prosthesis replacement for proximal femoral fractures. Eklem Hastalık Cerrahisi. 2009;20:11-7.
  3. Meyer HE, Tverdal A, Falch JA, Pedersen JI. Factors associated with mortality after hip fracture. Osteoporos Int. 2000;11:228-32. https://doi.org/10.1007/s001980050285
  4. Kuo LT, Lin SJ, Hsu WH, Peng KT et al. The effect of renal function on surgical outcomes of intracapsular hip fractures with osteosynthesis. Arch Orthop Trauma Surg. 2014;134:39-45. https://doi.org/10.1007/s00402-013-1884-5
  5. Alem AM, Sherrard DJ, Gillen DL, Weiss NS et al. Increased risk of hip fracture among patients with end-stage renal disease. Kidney Int. 2000;58:396-9. https://doi.org/10.1046/j.1523-1755.2000.00178.x
  6. Lindberg JS, Moe SM. Osteoporosis in end-stage renal disease. Semin Nephrol. 1999;19:115-22.
  7. Lin JC, Liang WM. Mortality and complications after hip fracture among elderly patients undergoing hemodialysis. BMC Nephrol. 2015;16:100. https://doi.org/10.1186/s12882-015-0099-0
  8. Lowrie EG, Curtin RB, LePain N, Schatell D. Medical outcomes study short form-36: a consistent and powerful predictor of morbidity and mortality in dialysis patients. Am J Kidney Dis. 2003;41:1286-92. https://doi.org/10.1016/S0272-6386(03)00361-5
  9. Pifer TB, McCullough KP, Port FK, Goodkin DA et al. Mortality risk in hemodialysis patients and changes in nutritional indicators: DOPPS. Kidney Int. 2002;62:2238-45. https://doi.org/10.1046/j.1523-1755.2002.00658.x
  10. Mittalhenkle A, Gillen DL, Stehman-Breen CO. Increased risk of mortality associated with hip fracture in the dialysis population. Am J Kidney Dis. 2004;44:672-9. https://doi.org/10.1016/S0272-6386(04)00958-8
  11. Tierney GS, Goulet JA, Greenfield ML, Port FK. Mortality after fracture of the hip in patients who have end-stage renal disease. J Bone Joint Surg Am. 1994;76:709-12. https://doi.org/10.2106/00004623-199405000-00012
  12. Karaeminogullari O, Demirors H, Sahin O, Ozalay M et al. Analysis of outcomes for surgically treated hip fractures in patients undergoing chronic hemodialysis. J Bone Joint Surg Am. 2007;89:324-31.
  13. Moran CG, Wenn RT, Sikand M, Taylor AM. Early mortality after hip fracture: is delay before surgery important? J Bone Joint Surg Am. 2005;87:483-9